Emily Bodnar
Stock Analyst at HC Wainwright & Co.
(0.90)
# 3,803
Out of 4,918 analysts
315
Total ratings
25.72%
Success rate
-24.56%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Emily Bodnar
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SABS SAB Biotherapeutics | Maintains: Buy | $10 → $9 | $2.32 | +287.95% | 2 | Jul 22, 2025 | |
| INKT MiNK Therapeutics | Downgrades: Neutral | $35 | $13.69 | +155.75% | 13 | Jul 15, 2025 | |
| RAPT RAPT Therapeutics | Maintains: Buy | $6 → $27 | $10.76 | +150.93% | 2 | Jul 10, 2025 | |
| JSPR Jasper Therapeutics | Maintains: Buy | $40 → $20 | $2.95 | +577.97% | 10 | Jul 7, 2025 | |
| NXTC NextCure | Reiterates: Buy | $36 | $5.18 | +595.65% | 9 | Jul 1, 2025 | |
| FEMY Femasys | Reiterates: Buy | $12 | $0.80 | +1,400.00% | 24 | Jun 25, 2025 | |
| ACLX Arcellx | Reiterates: Buy | $115 | $72.14 | +59.41% | 13 | Jun 16, 2025 | |
| ARTV Artiva Biotherapeutics | Assumes: Buy | $12 | $3.11 | +285.85% | 1 | Jun 11, 2025 | |
| AGEN Agenus | Upgrades: Buy | $25 | $5.45 | +359.14% | 18 | Jun 4, 2025 | |
| ANAB AnaptysBio | Upgrades: Buy | $22 → $38 | $24.53 | +54.91% | 10 | Jun 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $5.47 | +448.45% | 20 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $4.17 | +164.11% | 11 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $32 | $0.76 | +4,089.58% | 14 | Apr 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $560 → $280 | $11.52 | +2,331.61% | 17 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $36 | $14.75 | +144.07% | 1 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $1.96 | +308.16% | 6 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 | $2.12 | +466.04% | 13 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $3.53 | +749.86% | 7 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $19 | $1.31 | +1,350.38% | 12 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18 | $2.15 | +739.16% | 15 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $210 | $9.16 | +2,192.58% | 12 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $0.84 | +737.82% | 14 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $0.69 | +627.17% | 11 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $1.23 | - | 5 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $24 | $9.27 | +158.90% | 5 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $58 | $35.23 | +64.63% | 1 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18 | $0.68 | +2,533.12% | 1 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $2.74 | - | 15 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $38 | $11.69 | +225.06% | 18 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $33 | $2.34 | +1,310.26% | 14 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $5.31 | - | 1 | Apr 25, 2024 |
SAB Biotherapeutics
Jul 22, 2025
Maintains: Buy
Price Target: $10 → $9
Current: $2.32
Upside: +287.95%
MiNK Therapeutics
Jul 15, 2025
Downgrades: Neutral
Price Target: $35
Current: $13.69
Upside: +155.75%
RAPT Therapeutics
Jul 10, 2025
Maintains: Buy
Price Target: $6 → $27
Current: $10.76
Upside: +150.93%
Jasper Therapeutics
Jul 7, 2025
Maintains: Buy
Price Target: $40 → $20
Current: $2.95
Upside: +577.97%
NextCure
Jul 1, 2025
Reiterates: Buy
Price Target: $36
Current: $5.18
Upside: +595.65%
Femasys
Jun 25, 2025
Reiterates: Buy
Price Target: $12
Current: $0.80
Upside: +1,400.00%
Arcellx
Jun 16, 2025
Reiterates: Buy
Price Target: $115
Current: $72.14
Upside: +59.41%
Artiva Biotherapeutics
Jun 11, 2025
Assumes: Buy
Price Target: $12
Current: $3.11
Upside: +285.85%
Agenus
Jun 4, 2025
Upgrades: Buy
Price Target: $25
Current: $5.45
Upside: +359.14%
AnaptysBio
Jun 4, 2025
Upgrades: Buy
Price Target: $22 → $38
Current: $24.53
Upside: +54.91%
Apr 28, 2025
Reiterates: Buy
Price Target: $30
Current: $5.47
Upside: +448.45%
Apr 24, 2025
Reiterates: Buy
Price Target: $11
Current: $4.17
Upside: +164.11%
Apr 22, 2025
Reiterates: Buy
Price Target: $32
Current: $0.76
Upside: +4,089.58%
Apr 16, 2025
Maintains: Buy
Price Target: $560 → $280
Current: $11.52
Upside: +2,331.61%
Apr 9, 2025
Initiates: Buy
Price Target: $36
Current: $14.75
Upside: +144.07%
Apr 1, 2025
Reiterates: Buy
Price Target: $8
Current: $1.96
Upside: +308.16%
Apr 1, 2025
Reiterates: Buy
Price Target: $12
Current: $2.12
Upside: +466.04%
Mar 31, 2025
Reiterates: Buy
Price Target: $30
Current: $3.53
Upside: +749.86%
Mar 28, 2025
Reiterates: Buy
Price Target: $19
Current: $1.31
Upside: +1,350.38%
Mar 27, 2025
Reiterates: Buy
Price Target: $18
Current: $2.15
Upside: +739.16%
Mar 26, 2025
Reiterates: Buy
Price Target: $210
Current: $9.16
Upside: +2,192.58%
Mar 26, 2025
Reiterates: Buy
Price Target: $7
Current: $0.84
Upside: +737.82%
Mar 21, 2025
Reiterates: Buy
Price Target: $5
Current: $0.69
Upside: +627.17%
Mar 12, 2025
Reiterates: Neutral
Price Target: n/a
Current: $1.23
Upside: -
Feb 26, 2025
Upgrades: Buy
Price Target: $24
Current: $9.27
Upside: +158.90%
Feb 24, 2025
Reiterates: Buy
Price Target: $58
Current: $35.23
Upside: +64.63%
Feb 3, 2025
Reiterates: Buy
Price Target: $18
Current: $0.68
Upside: +2,533.12%
Jan 14, 2025
Reiterates: Neutral
Price Target: n/a
Current: $2.74
Upside: -
Jan 14, 2025
Reiterates: Buy
Price Target: $38
Current: $11.69
Upside: +225.06%
Nov 15, 2024
Reiterates: Buy
Price Target: $33
Current: $2.34
Upside: +1,310.26%
Apr 25, 2024
Reiterates: Neutral
Price Target: n/a
Current: $5.31
Upside: -